课题基金 / 基金详情

SFB 542: Molecular Mechanisms of Cytokine-Mediated Inflammatory Processes: Signal Transduction and Pathophysiological Consequences

SFB 542: Molecular Mechanisms of Cytokine-Mediated Inflammatory Processes: Signal Transduction and Pathophysiological Consequences
SFB 542:细胞因子介导的炎症过程的分子机制:信号转导和病理生理学后果
批准号:
5483639
负责人:
金额:
$0.0万
依托单位国家:
德国
项目类别:
Collaborative Research Centres
财政年份:
1999
资助国家:
德国
项目状态:
已结题
起止时间:
1998-12-31 至 2010-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Besides immuno-competent cells such as monocytes, macrophages, granulocytes and lymphocytes cells of inflamed tissues (endothelial cells, fibroblasts, keratinocytes, hepatocytes, hepatic stellate cells, mensangial cells or glial cells) are involved in the inflammatory response of the organism after infection and injury. The communication between these cells is brought about by cytokines. These polypeptide-mediators act through specific receptors on the surface of target cells. The molecular mechanisms by which these signals are transduced into the cell are not fully understood. The cellular responses range from altered gene expression, proliferation, differentiation, apoptosis, migration to degranulation. Dysregulation of signal transduction cascades and cytokine or receptor expression has been found to be the cause of several diseases. Due to these clinical implications, many academic and commercial research institutions are interested in cytokine-induced signal transduction cascades. The participating members of the collaborative research centre 542 are investigating the role of cytokine action in inflammatory diseases in order to understand their role in pathology. The results of these studies will serve as a rational basis for the development of new diagnostic tools and therapies for acute and chronic inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
靶向MiR-542-3p的中药配伍组分自组装新型纳米体系构建及抗卒中机制研究
  • 批准号:
    2025JJ80118
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    凌成利
  • 依托单位:
SHP2-Y542磷酸化在幼年型粒单核细胞白血病的临床诊断和靶向治疗中的应用与机制研究
  • 批准号:
    82372312
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    陈韵
  • 依托单位:
miRNA-542调控NFATC1/KANSL2抑制线粒体功能促进重症监护病房获得性肌无力的机制研究
  • 批准号:
    82301589
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    王韵
  • 依托单位:
内源性ADARs耦合CircRNA介导的RNA编辑体系在E542K/E545K突变型肺鳞癌